Objective: This study was undertaken to assess the effect of L-arginine at 8% on extended survival of rats with Walker 256 tumor. Method: The study is experimental, randomized, double blind. The animals for this experiment were divided in 3 groups. The first group (placebo) received gavage with water, seven days before the inoculation of Walker 256 tumor. The second group received 8% L-arginine solution of caloric ingestion 48 hours after the tumoral inoculation. The third group received 8% L-arginine solution of total caloric ingestion, initiated seven days before the tumoral inoculation. Results: The third group, supplemented seven days before the tumoral inoculation, presented greater extended survival (21 days, p=0.0001) when compared to animals from the other two. Animals supplemented 48 hours after the tumoral inoculation presented greater extended survival (20 days, p=0.0001) when compared to the placebo group (19 days, p=0.0001). Conclusion: The results suggest that both groups supplemented with 8% L-arginine presented beneficial results in respect to extended survival when compared to the placebo group, and better yet if the amino acid was administered before the tumoral inoculation.
Read full abstract